The Carlyle Group Inc.

  • Market Cap: Mid Cap
  • Industry: Capital Markets
  • ISIN: US14316J1088
USD
56.30
2.26 (4.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The Carlyle Group Inc. stock-summary
stock-summary
The Carlyle Group Inc.
Capital Markets
The Carlyle Group Inc., formerly The Carlyle Group L.P., is a diversified multi-product global alternative asset management firm. The Company advises on various investment funds and other investment vehicles that invests across a range of industries, geographies, asset classes and investment strategies, and seeks to deliver returns for its fund investors. The Company operates in four segments: Corporate Private Equity (CPE), Real Assets, Global Credit and Investment Solutions. The Corporate Private Equity segment is comprised of the operations that advise a diverse group of funds that invest in buyout, middle market and growth capital transactions that focus on either a geography or a particular industry. The Real Assets segment is comprised of the operations that advise United States and international funds focused on real estate, infrastructure, energy and renewable energy transactions.
Company Coordinates stock-summary
Company Details
C/O The Carlyle Group, 1001 Pennsylvania Avenue, N.W. WASHINGTON DC : 20004
stock-summary
Tel: 1 202 7295626
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 95 Schemes (30.19%)

Foreign Institutions

Held by 269 Foreign Institutions (10.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. William Conway
Co-Executive Chairman of the Board, Founder
Mr. David Rubenstein
Founder, Co-Executive Chairman, Director
Mr. Daniel D' Aniello
Founder, Chairman Emeritus and Director
Mr. Kewsong Lee
Chief Executive Officer, Director
Mr. Peter Clare
Chief Investment Officer for CPE, Co-Head of U.S. Buyout and Director
Mr. James Hance
Operating Executive, Director
Ms. Lawton Fitt
Independent Director
Ms. Janet Hill
Independent Director
Dr. Thomas Robertson
Independent Director
Mr. William Shaw
Independent Director
Mr. Anthony Welters
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,591 Million
(Quarterly Results - Jun 2025)
Net Profit:
328 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 23,203 Million (Mid Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

162.90%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

21.44%

stock-summary
Price to Book

3.96